Physical Therapy Central Of Bethany | |
8006 Nw 39th Expressway, Bethany, OK 73008-3005 | |
(405) 603-5222 | |
(405) 603-5557 |
Full Name | Physical Therapy Central Of Bethany |
---|---|
Type | Facility |
Speciality | Physical Therapist |
Location | 8006 Nw 39th Expressway, Bethany, Oklahoma |
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1972056786 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Physical Therapy Central Of Bethany 440 Merchant Dr, Norman, OK 73069-6470 Ph: (405) 809-8713 | Physical Therapy Central Of Bethany 8006 Nw 39th Expressway, Bethany, OK 73008-3005 Ph: (405) 603-5222 |
News Archive
Animals, insects, and plants use a variety of sensing mechanisms to detect invading pathogens such as viruses. One complex and effective antiviral defense system they share is based on recognition of double-stranded RNA, often produced when a virus invades a host cell.
Ikaria, Inc. announced today that its INOMAX® DS drug-delivery systems in the United States are being voluntarily recalled due to the potential failure of a pressure switch which may have an impact on the administration of INOMAX® (nitric oxide) for inhalation to patients. This potential failure was identified by Ikaria as part of its ongoing quality monitoring and review processes. This class I recall is being conducted with the knowledge of the U.S. Food and Drug Administration (FDA). All INOMAX DS systems in Canada also are being voluntarily recalled.
Join the American Association for Clinical Chemistry (AACC) and leading experts in laboratory medicine and diagnostic testing for a discussion of how laboratory medicine is driving the future of personalized medicine and the policies to support these new technologies.
Angiochem, a clinical stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier (BBB), today announced the initiation of a Phase 2 clinical study with ANG1005, a novel paclitaxel-peptide drug conjugate, in patients with recurrent high-grade glioma.
› Verified 4 days ago
Siera Alexis Hemans, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 6729 Nw 39th Expy, Bethany, OK 73008 Phone: 405-981-4001 | |
Alysson Stewart, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 6800 Nw 39th Expy, Bethany, OK 73008 Phone: 405-789-6711 Fax: 405-408-1235 | |
Brooke Foley, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 6800 Nw 39th Expy, Bethany, OK 73008 Phone: 405-789-6711 Fax: 405-438-3834 | |
Dr. Jenna L Anderson, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 6800 Nw 39th Expy, Bethany, OK 73008 Phone: 405-789-6711 Fax: 405-438-3834 | |
Kaitlyn Danae Miller, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 6800 Nw 39th Expy, Bethany, OK 73008 Phone: 405-789-6711 Fax: 405-438-3834 | |
Mary Johns, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 6800 Nw 39th Expy, Bethany, OK 73008 Phone: 405-440-9866 Fax: 405-782-0024 | |
Eugene Deloach Jr., DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 6729 Nw 39th Expy, Bethany, OK 73008 Phone: 405-717-6290 |